Brief: X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-The-Market
X4 Pharmaceuticals Inc XFOR.O :
* X4 PHARMACEUTICALS ANNOUNCES $65 MILLION PRIVATE PLACEMENT
PRICED AT-THE-MARKET
* X4 PHARMACEUTICALS INC - AGREED TO SELL AN AGGREGATE OF
42.8
MILLION SHARES OF COMMON STOCK IN A PRIVATE INVESTMENT IN PUBLIC
EQUITY FINANCING
* X4 PHARMACEUTICALS INC - INCLUSIVE OF NET PROCEEDS FROM
TRANSACTION, NOW EXPECTS ITS CASH & CASH EQUIVALENTS TO FUND
OPERATIONS INTO Q4 OF 2024
Source text for Eikon: ID:nGNX5hNRfQ
Further company coverage: XFOR.O
Recent news on X4 Pharmaceuticals
See all newsBrief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million
X4 Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule